Accession Number: | 0001415889-20-000055 |
Date: | 2020-01-02 |
Issuer: | AMPIO PHARMACEUTICALS, INC. (AMPE) |
Original Submission Date: |
GILES RICHARD B
C/O AMPIO PHARMACEUTICALS, INC.
373 INVERNESS PARKWAY, SUITE 200
ENGLEWOOD, CO 80112
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-01-02 | A | 34,059 | a | $0.59 | 301,353 | direct | ||
COMMON STOCK | 2020-01-02 | 0 | $0.00 | 50,417 | indirect | ||||
COMMON STOCK | 2020-01-02 | 0 | $0.00 | 1,838 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the shares were issued to the reporting person under the issuer's 2019 stock option and incentive plan and pursuant to compensation agreements approved by the board of directors of the issuer. |